期刊
JOURNAL OF MICROENCAPSULATION
卷 28, 期 4, 页码 301-310出版社
INFORMA HEALTHCARE
DOI: 10.3109/02652048.2011.559281
关键词
chitosan; drug targeting; leishmaniasis; macrophage uptake; microparticles; passive targeting
The potential of chitosan microparticles as a carrier of doxorubicin for the treatment of visceral leishmaniasis was evaluated by macrophage-mediated drug targeting approach. Cationic charge of doxorubicin was masked by complexing it with dextran sulphate (a poly anion) in order to facilitate its incorporation into cationic chitosan microparticles. Prior to in vitro and in vivo studies, characterization studies were carried out systematically: particle size (similar to 1.049 mu A mu m), surface morphology (fluorescence microscopy -- spherical structured microparticles), Fourier transform infrared spectroscopy (to characterize effective cross-linking) and differential scanning calorimetry. In vitro studies were carried out in J774.1 in order to check the effective endocytotic uptake of microparticles by macrophages. In vivo studies were conducted in Syrian golden hamsters as per well-established protocols and the results drawn from in vivo studies displayed substantial reduction in leishmanial parasite load for doxorubicin-encapsulated chitosan microparticles: similar to 78.2 +/-+/- 10.4%%, when compared to the control (free doxorubicin): 33.3 +/-+/- 2.4%%.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据